Implications of RAS mutational status in subsets of patients with newly diagnosed acute myeloid leukemia across therapy subtypes
暂无分享,去创建一个
K. Bhalla | G. Garcia-Manero | T. Kadia | F. Ravandi | Koichi Takahashi | G. Borthakur | E. Jabbour | C. Dinardo | R. Kanagal-Shamanna | N. Pemmaraju | N. Short | G. Montalban-Bravo | H. Kantarjian | Kunhwa Kim | N. Daver | D. Rivera | M. Yilmaz | S. Pierce | M. Konopleva | Naval G Daver